ANEMIAS (IRON DEFICIENCY, PERNICIOUS, APLASTIC, HEMOLYTIC)
Anemia is a symptom of an underlying condition, such as loss of blood components, inadequate elements, or lack of required nutrients for the formation of blood cells, that results in decreased oxygen-carrying capacity of the blood. There are numerous types of anemias with various causes. The following types of anemia are discussed here: iron deficiency (ID), the result of inadequate absorption or excessive loss of iron; pernicious (PA), the result of a lack of the intrinsic factor essential for the absorption of vitamin B12; aplastic, due to failure of bone marrow; and hemolytic, due to red blood cell (RBC) destruction. Nursing care for the anemic patient has a common theme even though the medical treatments vary widely.
CARE SETTING
Treated at the community level, except in the presence of severe cardiovascular/immune compromise.
RELATED CONCERNS
AIDS
Burns: thermal/chemical/electrical (acute and convalescent phases)
Cancer
Cirrhosis of the liver
Heart failure: Chronic
Psychosocial aspects of care
Renal failure: acute
Renal failure: chronic
Rheumatoid arthritis
Pulmonary tuberculosis (TB)
Upper gastrointestinal/esophageal bleeding
Patient Assessment Database
ACTIVITY/REST
May report:               Fatigue, weakness, general malaise
                                    Loss of productivity; diminished enthusiasm for work
                                    Low exercise tolerance
                                    Greater need for rest and sleep
May exhibit:              Tachycardia/tachypnea; dyspnea on exertion or at rest (severe or aplastic anemia)
                                    Lethargy, withdrawal, apathy, lassitude, and lack of interest in surroundings
                                    Muscle weakness and decreased strength
                                    Ataxia, unsteady gait
                                    Slumping of shoulders, drooping posture, slow walk, and other cues indicative of fatigue
CIRCULATION
May report:               History of chronic blood loss, e.g., chronic gastrointestinal bleeding, heavy menses (ID); angina, heart failure (HF) (due to increased cardiac workload)
                                    History of chronic infective endocarditis
                                    Palpitations (compensatory tachycardia)
May exhibit:              Blood pressure (BP): Increased systolic with stable diastolic and a widened pulse pressure; postural hypotension
                                    Dysrhythmias, electrocardiogram abnormalities, e.g., ST-segment depression and flattening or depression of the T wave; tachycardia
                                    Throbbing carotid pulsations (reflects increased cardiac output as a compensatory mechanism to provide oxygen/nutrients to cells)
                                    Systolic murmur (ID)
                                    Extremities (color): Pallor of the skin and mucous membranes (conjunctiva, mouth, pharynx, lips) and nailbeds, or grayish cast in black patients; waxy, pale skin (aplastic, PA) or bright lemon yellow (PA)
                                    Sclera blue or pearl white (ID); jaundice (PA)
                                    Capillary refill delayed (diminished blood flow to the periphery and compensatory vasoconstriction)
                                    Nails brittle, spoon-shaped (koilonychia) (ID)
EGO INTEGRITY
May report:               Negative feelings about self, ability to handle situation/events
May exhibit:              Depression
ELIMINATION
May report:               History of pyelonephritis, renal failure
                                    Flatulence, malabsorption syndrome (ID)
                                    Hematemesis, fresh blood in stool, melena
                                    Diarrhea or constipation
                                    Diminished urine output
May exhibit:              Abdominal distension
FOOD/FLUID
May report:               Decreased dietary intake, low intake of animal protein/high intake of cereal products (ID)
                                    Mouth or tongue pain, difficulty swallowing (ulcerations in pharynx)
                                    Nausea/vomiting, dyspepsia, anorexia
                                    Recent weight loss
                                    Insatiable craving or pica for ice, dirt, cornstarch, paint, clay, and so forth (ID)
May exhibit:              Beefy red/smooth appearance of tongue (PA; folic acid and vitamin B12 deficiencies)
                                    Dry, pale mucous membranes
                                    Skin turgor poor with dry, shriveled appearance/loss of elasticity (ID)
                                    Stomatitis and glossitis (deficiency states)
                                    Lips: Cheilitis, i.e., inflammation of the lips with cracking at the corners of the mouth (ID)
HYGIENE
May report:               Difficulty maintaining activities of daily living (ADLs)
May exhibit:              Unkempt appearance, poor personal hygiene
                                    Hair dry, brittle, thinning; premature graying (PA)
NEUROSENSORY
May report:               Headaches, fainting, dizziness, vertigo, tinnitus, inability to concentrate
                                    Insomnia, dimness of vision, and spots before eyes
                                    Weakness, poor balance, wobbly legs; paresthesias of hands/feet (PA); claudication
                                    Sensation of being cold
May exhibit:              Irritability, restlessness, depression, drowsiness, apathy
                                    Mentation: Notable slowing and dullness in response
                                    Ophthalmic: Retinal hemorrhages (aplastic, PA)
                                    Epistaxis, bleeding from other orifices (aplastic)
                                    Disturbed coordination, ataxia; decreased vibratory and position sense, positive Romberg’s sign, paralysis (PA)
PAIN/DISCOMFORT
May report:               Vague abdominal pains; headache (ID)
                                    Oral pain
RESPIRATION
May report:               History of TB, lung abscesses
                                    Shortness of breath at rest and with activity
May exhibit:              Tachypnea, orthopnea, and dyspnea
SAFETY
May report:               History of occupational exposure to chemicals, e.g., benzene, lead, insecticides, phenylbutazone, naphthalene
                                    History of exposure to radiation either as a treatment modality or by accident
                                    History of cancer, cancer therapies
                                    Cold and/or heat intolerance
                                    Previous blood transfusions
                                    Impaired vision
                                    Poor wound healing, frequent infections
May exhibit:              Low-grade fever, chills, night sweats
                                    Generalized lymphadenopathy
                                    Petechiae and ecchymosis (aplastic)
SEXUALITY
May report:               Changes in menstrual flow, e.g., menorrhagia or amenorrhea in women (ID)
                                    Loss of libido (men and women)
                                    Impotence in men
May exhibit:              Pale cervix and vaginal walls
TEACHING/LEARNING
May report:               Family tendency for anemia (ID, PA)
                                    Past/present use of anticonvulsants, antibiotics, chemotherapeutic agents (bone marrow failure), aspirin, anti-inflammatory drugs, or anticoagulants
                                    Chronic use of alcohol
                                    Religious/cultural beliefs affecting treatment choices, e.g., refusal of blood transfusions
                                    Recent/current episode of active bleeding (ID)
                                    History of liver, renal disease; hematologic problems; celiac or other malabsorption disease; regional enteritis; tapeworm manifestations; polyendocrinopathies; autoimmune problem (e.g., antibodies to parietal cells, intrinsic factor, thyroid and T-cell antibodies)
                                    Prior surgeries, e.g., splenectomy; tumor excision; prosthetic valve replacement; surgical excision of duodenum or gastric resection, partial/total gastrectomy (ID, PA)
                                    History of problems with wound healing or bleeding; chronic infections, chronic granulomatous disease, or cancer (secondary anemias)
Discharge plan        DRG projected mean length of inpatient stay: 4.3 days or depending on type/cause of anemia and severity of complications
considerations:     May require assistance with treatment (injections); self-care activities and/or homemaker/maintenance tasks; changes in dietary plan
                                    Refer to section at end of plan for postdischarge considerations.
DIAGNOSTIC STUDIES
Complete blood count (CBC):
Hemoglobin (Hb) and hematocrit (Hct): Decreased in anemias and overhydration caused by excessive IV fluids, bleeding problems, bone marrow suppression.
Erythrocyte (RBC) count: Decreased (PA), severely decreased (aplastic); mean corpuscular volume (MCV) and mean corpuscular hemoglobin (MCH) decreased and microcytic with hypochromic erythrocytes (ID), elevated (PA); pancytopenia (aplastic).
Stained RBC examination: Detects changes in color and shape (may indicate particular type of anemia).
Reticulocyte count: Varies; helps assess bone marrow function, e.g., decreased (PA, cirrhosis, folic acid deficiency, bone marrow failure, radiation therapy); elevated (blood loss/hemolysis, leukemias, compensated anemias).
White blood cells (WBCs): Total cell count and specific WBCs (differential) may be increased (hemolytic) or decreased (aplastic).
Platelet count: Decreased (aplastic); elevated (ID); normal or high (hemolytic).
Erythrocyte sedimentation rate (ESR): Elevation indicates presence of inflammatory reaction, e.g., increased RBC destruction or malignant disease.
RBC survival time: Useful in the differential diagnosis of anemias because RBCs have shortened life spans in pernicious and hemolytic anemias.
Erythrocyte fragility test: Decreased (ID); increased fragility confirms hemolytic and autoimmune anemias.
Hemoglobin electrophoresis: Identifies type of hemoglobin structure, aids in determining source of hemolytic anemia.
Serum folate and vitamin B12: Aids in diagnosing anemias related to deficiencies in dietary intake/malabsorption.
Serum iron: Absent (ID); elevated (hemolytic, aplastic).
Serum total iron-binding capacity (TIBC): Increased (ID); normal or slightly reduced (AP).
Serum ferritin: Decreased (ID).
Serum bilirubin (unconjugated): Elevated (PA, hemolytic).
Serum lactate dehydrogenase (LDH): May be elevated (PA).
Bleeding time: Prolonged (aplastic).
Schilling’s test: Decreased urinary excretion of vitamin B12 (PA).
Guaiac: May be positive for occult blood in urine, stools, and gastric contents, reflecting acute/chronic bleeding (ID).
Gastric analysis: Decreased secretions with elevated pH and absence of free HCl (PA).
Bone marrow aspiration/biopsy examination: Cells may show changes in number, size, and shape, helping to differentiate type of anemia, e.g., increased megaloblasts (PA); fatty marrow with diminished or absence of blood cells at several sites (aplastic).
Endoscopic and radiographic studies: Checks for bleeding sites, e.g., acute/chronic gastrointestinal (GI) bleeding.
NURSING PRIORITIES
1.  Enhance tissue perfusion.
2.  Provide nutritional/fluid needs.
3.  Prevent complications.
4.  Provide information about disease process, prognosis, and treatment regimen.
DISCHARGE GOALS
1.  ADLs met by self or with assistance of others.
2.  Complications prevented/minimized.
3.  Disease process/prognosis and therapeutic regimen understood.
4.  Plan in place to meet needs after discharge.
|     NURSING DIAGNOSIS: Activity intolerance May be related to Imbalance between oxygen supply   (delivery) and demand Possibly evidenced by Weakness and fatigue Reports of decreased exercise/activity   tolerance Greater need for sleep/rest Palpitations, tachycardia, increased   BP/respiratory response with minor exertion DESIRED OUTCOMES/EVALUATION   CRITERIA—PATIENT WILL: Endurance (NOC) Report an increase in activity   tolerance (including ADLs). Demonstrate a decrease in physiological   signs of intolerance, e.g., pulse, respirations, and BP remain within   patient’s normal range. Display laboratory values, e.g., Hb/Hct, within   acceptable range.  |   
|     ACTIONS/INTERVENTIONS Energy Management (NIC) Independent Assess patient’s ability to perform   normal tasks/ADLs, noting reports of weakness, fatigue, and difficulty   accomplishing tasks. Note changes in balance/gait   disturbance, muscle weakness. Monitor BP, pulse, respirations   during and after activity. Note adverse responses to increased levels of   activity(e.g., increased heart rate [HR]/BP, dysrhythmias, dizziness,   dyspnea, tachypnea, cyanosis of mucous membranes/nailbeds). Recommend quiet atmosphere; bedrest   if indicated. Stress need to monitor and limit visitors, phone calls, and   repeated unplanned interruptions. Elevate head of bed as tolerated. Suggest patient change position   slowly; monitor for dizziness. Assist patient to prioritize   ADLs/desired activities. Alternate rest periods with activity periods. Write   out schedule for patient to refer to. Provide/recommend assistance with   activities/ambulation as necessary, allowing patient to do as much as   possible. Plan activity progression with   patient, including activities that patient views as essential. Increase   activity levels as tolerated. Identify/implement energy-saving   techniques, e.g., shower chair, sitting to perform tasks. Instruct patient to stop activity if   palpitations, chest pain, shortness of breath, weakness, or dizziness occur. Discuss importance of maintaining   environmental temperature and body warmth as indicated.  |        RATIONALE Influences choice of   interventions/needed assistance. May indicate neurological changes   associated with vitamin B12 deficiency, affecting patient   safety/risk of injury. Cardiopulmonary manifestations result   from attempts by the heart and lungs to supply adequate amounts of oxygen to   the tissues. Enhances rest to lower body’s oxygen   requirements, and reduces strain on the heart and lungs. Enhances lung expansion to maximize   oxygenation for cellular uptake. Note: May be contraindicated if   hypotension is present. Postural hypotension or cerebral   hypoxia may cause dizziness, fainting, and increased risk of injury. Promotes adequate rest, maintains   energy level, and alleviates strain on the cardiac and respiratory systems. Although help may be necessary,   self-esteem is enhanced when patient does some things for self. Promotes gradual return to normal   activity level and improved muscle tone/stamina without undue fatigue.   Increases self-esteem and sense of control. Encourages patient to do as much as   possible, while conserving limited energy and preventing fatigue. Cellular ischemia potentiates risk of   infarction and excessive cardiopulmonary strain/stress may lead to   decompensation/failure. Vasoconstriction (shunting of blood   to vital organs) decreases peripheral circulation, impairing tissue   perfusion. Patient’s comfort/need for warmth must be balanced with need to   avoid excessive heat with resultant vasodilation (reduces organ perfusion).  |   
|     ACTIONS/INTERVENTIONS Energy Management (NIC) Collaborative Monitor laboratory studies, e.g., Hb/Hct and RBC count,   arterial blood gases (ABGs). Provide supplemental oxygen as indicated. Administer as indicated: Colony-stimulating factors (CSFs), e.g., aldesleukin   (Interleukin-2); Whole blood/packed RBCs (PRCs), blood products as   indicated. Monitor closely for transfusion reactions. Prepare for surgical intervention if indicated.  |        RATIONALE Identifies deficiencies in RBC components affecting   oxygen transport and treatment needs/response to therapy. Maximizing oxygen transport to tissues improves ability   to function. CSFs may be given to stimulate growth of specific blood   elements. Increases number of oxygen-carrying cells; corrects   deficiencies to reduce risk of hemorrhage in acutely compromised individuals.   Note: Transfusions are reserved for severe blood loss anemias with   cardiovascular compromise; used after other therapies have failed to restore   homeostasis. Bone marrow transplant may be done in presence of bone   marrow failure/aplastic anemia.  |   
|     NURSING DIAGNOSIS: Nutrition: imbalanced, less than body requirements May be related to Failure to ingest or inability to   digest food/absorb nutrients necessary for formation of normal RBCs Possibly evidenced by Weight loss/weight below normal for   age, height, and build Decreased triceps skin-fold measurement Changes in gums, oral mucous membranes Decreased tolerance for activity,   weakness, and loss of muscle tone DESIRED OUTCOMES/EVALUATION   CRITERIA—PATIENT WILL: Nutritional Status (NOC) Demonstrate progressive weight gain or   stable weight, with normalization of laboratory values. Experience no signs of malnutrition. Demonstrate behaviors, lifestyle changes to regain and/or   maintain appropriate weight.  |   
|     ACTIONS/INTERVENTIONS Nutrition Therapy (NIC) Independent Review nutritional history, including   food preferences.  |        RATIONALE Identifies deficiencies, suggests   possible interventions.  |   
|     ACTIONS/INTERVENTIONS Nutrition Therapy (NIC) Independent Observe   and record patient’s food intake. Weigh   periodically as appropriate (e.g., weekly). Recommend   small, frequent meals and/or between-meal nourishment. Suggest   bland diet, low in roughage, avoiding hot, spicy, or very acidic foods as   indicated. Have   patient record and report occurrence of nausea/ vomiting, flatus, and other   related symptoms such as irritability or impaired memory. Encourage/assist   with good oral hygiene; before and after meals, use soft-bristled toothbrush   for gentle brushing. Provide dilute, alcohol-free mouthwash if oral mucosa is   ulcerated. Collaborative Consult   with dietitian. Monitor   laboratory studies, e.g., Hb/Hct, blood urea nitrogen (BUN),   prealbumin/albumin, protein, transferrin, serum iron, vitamin B12,   folic acid, TIBC, serum electrolytes. Administer medications as indicated, e.g.: Vitamin and mineral supplements, e.g., cyanocobalamin   (vitamin B12), folic acid (Folvite), ascorbic acid (vitamin C); Oral iron supplements, e.g., ferrous sulfate (Feosol,   Mol-Iron, Fer-In-Sol), ferrous gluconate (Fergon), ferrous fumarate (Ircon,   Femiron); Iron dextran (InFeD) IM/IV; Antifungal or anesthetic mouthwash, if indicated.  |        RATIONALE Monitors   caloric intake or insufficient quality of food consumption. Monitors   weight loss and effectiveness of nutritional interventions. May   reduce fatigue and thus enhance intake while preventing gastric distension.   Use of Ensure/Isomil or similar product provides additional protein and   calories. When   oral lesions are present, pain may restrict type of foods patient can   tolerate. May   reflect effects of anemias (hypoxia, vitamin B12 deficiency) on   organs. Enhances   appetite and oral intake. Diminishes bacterial growth, minimizing possibility   of infection. Special mouth-care techniques may be needed if tissue is   fragile/ulcerated/bleeding and pain is severe. Aids   in establishing dietary plan to meet individual needs. Evaluates   effectiveness of treatment regimen, including dietary sources of needed   nutrients. Replacements   needed depend on type of anemia and/or presence of poor oral intake and   identified deficiencies. May   be useful in some types of iron deficiency anemias. Oral preparations are   taken between meals to enhance absorption and usually correct anemia and   replace iron stores over a period of several months. Administered   until estimated deficit is corrected. Reserved for those who cannot absorb or   comply with oral iron therapy or when blood loss is too rapid for oral   replacement to be effective. May   be needed in the presence of stomatitis/glossitis to promote oral tissue   healing and facilitate intake.  |   
|     NURSING DIAGNOSIS: Constipation/Diarrhea May be related to Decreased dietary intake; changes in   digestive processes Drug therapy side effects Possibly evidenced by Changes in frequency, characteristics,   and amount of stool Nausea/vomiting, decreased appetite Reports of abdominal pain, urgency,   cramping Altered bowel sounds DESIRED OUTCOMES/EVALUATION   CRITERIA—PATIENT WILL: Bowel Elimination (NOC) Establish/return to normal patterns of   bowel functioning. Demonstrate changes in behaviors/lifestyle, as   necessitated by causative, contributing factors.  |   
|     ACTIONS/INTERVENTIONS Bowel Management (NIC) Independent Determine stool color, consistency,   frequency, and amount. Auscultate bowel sounds. Monitor intake and output (I&O)   with specific attention to food/fluid intake. Encourage fluid intake of 2500–3000   mL/day within cardiac tolerance. Recommend avoiding gas-forming foods. Assess perianal skin condition   frequently, noting changes or beginning breakdown. Encourage/assist with   perineal care after each bowel movement (BM) if diarrhea is present. Discuss use of stool softeners, mild   stimulants, bulk-forming laxatives, or enemas as indicated. Monitor   effectiveness.  |        RATIONALE Assists in identifying   causative/contributing factors and appropriate interventions. Bowel sounds are generally increased   in diarrhea and decreased in constipation. May identify dehydration, excessive   loss of fluids or aid in identifying dietary deficiencies. Assists in improving stool   consistency if constipated. Helps maintain hydration status if diarrhea is   present. Decreases gastric distress and   abdominal distension. Prevents skin excoriation and   breakdown. Facilitates defecation when   constipation is present.  |   
|     ACTIONS/INTERVENTIONS Bowel Management (NIC) Collaborative Consult with dietitian to provide well-balanced diet high   in fiber and bulk. Administer antidiarrheal medications, e.g., diphenoxylate   hydrochloride with atropine (Lomotil), and water-absorbing drugs, e.g.,   Metamucil.  |        RATIONALE Fiber resists enzymatic digestion and absorbs liquids in   its passage along the intestinal tract and thereby produces bulk, which acts   as a stimulant to defecation. Decreases intestinal motility when diarrhea is present.  |   
|     NURSING DIAGNOSIS: Infection, risk for Risk factors may include Inadequate secondary defenses, e.g.,   decreased hemoglobin, leukopenia, or decreased granulocytes (suppressed   inflammatory response) Inadequate primary defenses, e.g.,   broken skin, stasis of body fluids; invasive procedures; chronic disease,   malnutrition Possibly evidenced by [Not applicable; presence of signs and   symptoms establishes an actual diagnosis.] DESIRED OUTCOMES/EVALUATION   CRITERIA—PATIENT WILL: Risk Control (NOC) Identify behaviors to prevent/reduce   risk of infection. Immune Status (NOC) Be free of signs of infection, achieve timely wound   healing (if present).  |   
|     ACTIONS/INTERVENTIONS Infection Protection (NIC) Independent Perform/promote meticulous   handwashing by caregivers and patient. Maintain strict aseptic techniques   with procedures/wound care. Provide meticulous skin, oral, and   perianal care. Encourage frequent position changes/   ambulation, coughing, and deep-breathing exercises.  |        RATIONALE Prevents   cross-contamination/bacterial colonization. Note: Patient with   severe/aplastic anemia may be at risk from normal skin flora. Reduces risk of bacterial   colonization/infection. Reduces risk of skin/tissue breakdown   and infection. Promotes ventilation of all lung   segments and aids in mobilizing secretions to prevent pneumonia.  |   
|     ACTIONS/INTERVENTIONS Infection Protection (NIC) Independent Promote adequate fluid intake. Stress need to monitor/limit visitors. Provide protective   isolation if appropriate. Restrict live plants/cut flowers. Monitor temperature. Note presence of chills and   tachycardia with/without fever. Observe for wound erythema/drainage. Collaborative Obtain specimens for culture/sensitivity as indicated. Administer topical antiseptics; systemic antibiotics.  |        RATIONALE Assists in liquefying respiratory secretions to   facilitate expectoration and prevent stasis of body fluids (e.g., respiratory   and renal). Limits exposure to bacteria/infections. Protective   isolation may be required in aplastic anemia, when immune response is most   compromised. Reflective of inflammatory process/ infection, requiring   evaluation and treatment. Note: With bone marrow suppression,   leukocytic failure may lead to fulminating infections. Indicators of local infection. Note: Pus formation   may be absent if granulocytes are depressed. Verifies presence of infection, identifies specific   pathogen, and influences choice of treatment. May be used prophylactically to reduce colonization or   used to treat specific infectious process.  |   
|     NURSING DIAGNOSIS: Knowledge, deficient [Learning Need] regarding   condition, prognosis, treatment, self-care, and discharge needs May be related to Lack of exposure/recall Information misinterpretation Unfamiliarity with information   resources Possibly evidenced by Questions; request for information;   statement of misconception Inaccurate follow-through of   instructions, development of preventable complications DESIRED OUTCOMES/EVALUATION   CRITERIA—PATIENT WILL: Knowledge: Illness Care (NOC) Verbalize understanding of the nature   of the disease process, diagnostic procedures, and potential complications. Identify causative factors. Verbalize understanding of therapeutic   needs. Initiate necessary behaviors/lifestyle changes.  |   
|     ACTIONS/INTERVENTIONS Teaching: Disease Process (NIC) Independent Provide information about specific   anemia and explain that therapy depends on the type and severity of the   anemia. Discuss effects of anemias on   preexisting conditions. Review purpose and preparations for   diagnostic studies. Explain that blood taken for   laboratory studies will not worsen anemia. Review required diet alterations to   meet specific dietary needs (determined by type of anemia/deficiency). Assess resources (e.g., financial)   and ability to obtain/prepare food). Encourage cessation of smoking. Provide information about purpose,   dosage, schedule, precautions and potential side effects, interactions, and   adverse reactions to all prescribed medications. Stress importance of reporting signs   of fatigue, weakness, paresthesias, irritability, impaired memory. Instruct and demonstrate   self-administration of oral iron preparations: Discuss importance of taking only   prescribed dosages; Advise taking with meals or   immediately after meals; Dilute liquid preparations   (preferably with orange juice) and administer through a straw;  |        RATIONALE Provides knowledge base from which   patient can make informed choices. Allays anxiety and may promote cooperation   with therapeutic regimen. Anemias aggravate heart, lung, and   cerebrovascular disease. Anxiety/fear of the unknown increases   stress level, which in turn increases the cardiac workload. Knowledge of what   to expect can diminish anxiety. This is often an unspoken concern   that can potentiate patient’s anxiety. Red meat, liver, egg yolks, green   leafy vegetables, whole wheat bread, and dried fruits are sources of iron.   Green vegetables, whole grains, liver, and citrus fruits are sources of folic   acid and vitamin C (enhances absorption of iron). Inadequate resources may affect   ability to purchase/prepare appropriate food items. Smoking decreases available oxygen   and causes vasonstriction. Information enhances cooperation with   regimen. Recovery from anemias can be slow, requiring lengthy treatment and   prevention of secondary complications. Indicates that anemia is progressing   or failing to resolve, necessitating further evaluation/treatment changes. Iron replacement usually takes 3–6   mo, whereas vitamin B12 injections may be necessary for the rest   of patient’s life. Overdose of iron medication can be   toxic. Iron is best absorbed on an empty   stomach. However, iron salts are gastric irritants and may cause dyspepsia,   diarrhea, and abdominal discomfort if taken on an empty stomach. Undiluted liquid iron preparations   may stain the teeth. Ascorbic acid promotes iron absorption.  |   
|     ACTIONS/INTERVENTIONS Teaching: Disease Process (NIC) Independent Caution that BM may appear greenish black/tarry; Emphasize importance of good oral hygiene measures. Instruct patient/SO about parenteral iron administration,   e.g.: Z-track administration of medication; Use separate needles for withdrawing and injecting the   medication; Caution regarding possible systemic reaction, (e.g.,   flushing, vomiting, nausea, myalgia) and discuss importance of reporting   symptoms. Discuss increased susceptibility to infections, signs/   symptoms requiring medical intervention, e.g., fever, sore throat;   erythema/draining wound; cloudy urine, burning with urination. Identify safety concerns, e.g., avoidance of forceful   blowing of nose, contact sports, constipation/straining for stool; use of   electric razors, soft toothbrush. Recommend avoiding use of heating pads or hot water   bottles; measuring temperature of bath water with a thermometer. Recommend routine observation of skin, noting changes in   turgor, altered color, local warmth, erythema, excoriation. Identify measures for healthy skin, e.g.: Reposition periodically and gently massage bony surfaces   when sedentary or in bed; Keep skin surfaces dry and clean, limit use of soap; Engage regularly in range of motion (ROM) exercises;  |        RATIONALE Excretion of excessive iron changes stool color. Certain iron supplements (e.g., Feosol) may leave   deposits on teeth and gums. Prevents extravasation (leaking) with accompanying pain   and tissue damage. Medication may stain the skin. Possible side effects of therapy requiring reevaluation   of drug choice and dosage. Decreased leukocyte production potentiates risk of   infection. Note: Purulent drainage may not form in absence of   granulocytes (aplastic). Reduces risk of hemorrhage from fragile tissues and   general decrease of coagulation factors. Thermoreceptors in the dermal tissues may be dulled   because of oxygen deprivation, thus increasing the risk of thermal injury. Condition of the skin is affected by circulation,   nutrition, and immobility. Tissues may become fragile and prone to infection   and breakdown. Increases circulation to all skin areas, limiting tissue   ischemia/effects of cellular hypoxia. Moist, contaminated areas provide excellent media for   growth of pathogenic organisms. Soap may dry excessively and increase   irritation. Promotes circulation to tissues, prevents stasis.  |   
|     ACTIONS/INTERVENTIONS Reality Orientation (NIC) Independent Suggest use of protective devices, e.g., sheepskin,   egg-crate, alternating air pressure/water mattress, heel/elbow protectors,   and pillows as indicated. Review good oral hygiene, necessity for regular dental   care. Instruct to avoid use of aspirin products. Refer to appropriate community resources when indicated,   e.g., social services for food stamps, Meals on Wheels.  |        RATIONALE Avoids skin breakdown by preventing/reducing pressure   against skin surfaces. Effects of anemia (oral lesions) and/or iron supplements   increase risk of infection/bacteremia. Increases bleeding tendencies. May need assistance with groceries/meal preparation.  |   
POTENTIAL CONSIDERATIONS following acute hospitalization (dependent on patient’s age, physical condition/presence of complications, personal resources, and life responsibilities)
Activity intolerance—imbalance between oxygen supply (delivery) and demand.
Nutrition: imbalanced, less than body requirements—failure to ingest or inability to digest food/absorb nutrients necessary for formation of normal RBCs.
Infection, risk for—inadequate secondary defenses, e.g., decreased hemoglobin, leukopenia, or decreased granulocytes (suppressed inflammatory response); inadequate primary defenses, e.g., broken skin, stasis of body fluids; invasive procedures; chronic disease, malnutrition.
Therapeutic Regimen: ineffective management—economic difficulties, perceived benefits.


